Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors : Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study

DSpace/Manakin Repository

 
 
See more statistics about this item